Filter
739
Text search:
Chen,
Y.
Featured
Recommendations
68
New Publications
91
Language
Document type
No document type
273
Studies & Reports
191
Guidelines
186
Manuals
31
Fact sheets
28
Strategic & Response Plan
13
Training Material
12
Situation Updates
3
Infographics
2
Countries / Regions
Global
37
Russia
32
Brazil
23
India
20
Germany
17
Latin America and the Carribbean
17
Western and Central Europe
14
Middle East and North Africa
12
Peru
8
Eastern Europe
8
Burkina Faso
7
Syria
7
Kenya
7
Yemen
7
Africa
7
Sierra Leone
6
South Africa
6
Mozambique
6
West and Central Africa
6
Eastern Europe and Central Asia
6
Asia
6
Nigeria
5
Zimbabwe
5
Malawi
5
Argentina
5
Spain
5
Uganda
4
South Sudan
4
Benin
4
Ukraine
4
Ecuador
4
Bolivia
4
Angola
4
Chile
4
Paraguay
4
Vietnam
4
Mali
3
Ghana
3
Haiti
3
Philippines
3
Nepal
3
Tanzania
3
Cambodia
3
China
3
Indonesia
3
Lesotho
3
Myanmar / Burma
3
Canada
3
France
3
Guinea
2
Senegal
2
Guinea-Bissau
2
USA
2
Ethiopia
2
Cameroon
2
Niger
2
Pakistan
2
Rwanda
2
Bangladesh
2
Burundi
2
Colombia
2
Madagascar
2
East and Southern Africa
2
South–East Asia Region
2
Venezuela
2
Laos
2
Liberia
1
Congo, Democratic Republic of
1
Côte d’Ivoire / Ivory Coast
1
Togo
1
Afghanistan
1
Zambia
1
Thailand
1
Singapore
1
Papua New Guinea
1
Sudan
1
Eswatini/ Swaziland
1
Austria
1
Switzerland
1
Sri Lanka
1
Luxembourg
1
Italy
1
Djibouti
1
Mongolia
1
Congo-Brazzaville
1
Tajikistan
1
Qatar
1
Kyrgyzstan
1
Uruguay
1
Belgium
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
217
Clinical Guidelines
65
Public Health
54
Women & Child Health
26
Key Resources
14
Pharmacy & Technologies
7
Capacity Building
6
General Guidelines
1
Toolboxes
COVID-19
202
Mental Health
79
HIV
65
Planetary Health
50
TB
43
NCDs
38
Disability
22
NTDs
20
Caregiver
18
AMR
16
Rapid Response
14
Global Health Education
14
Zika
13
Pharmacy
13
Natural Hazards
8
Refugee
8
Health Financing Toolbox
8
Conflict
5
Ebola
3
Polio
2
Cholera
1
Social Ethics
1
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines
...
HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexuality; stigma and discrimination; gender discrimination
...
As a high-burden neglected tropical disease, soil-transmitted helminth (STH) infections remain a major problem in the world, especially among children under five years of age. Since young children are at high risk of being infected, STH infection can have a long-term negative impact on their life, i
...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sustainable Development Goals, when progress in reduci
...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. The aim of this work is to analyse the available data to answer clinical questions regarding medical t
...
In 2017, $37.4 billion of development assistance was provided to low- and middleincome countries to maintain or improve health. This amount is down slightly compared to 2016, and since 2010, development assistance for health (DAH) has grown at an annualized rate of 1.0%. While global development ass
...
The 2018 global health financing report presents health spending data for all WHO Member States between 2000 and 2016 based on the SHA 2011 methodology. It shows a transformation trajectory for the global spending on health, with increasing domestic public funding and declining external financing. T
...
The UK government hosted the Global Vaccine Summit on June 4, 2020 under the patronage of the Rt. Hon. Boris Johnson, Prime Minister of the United Kingdom of Great Britain and Northern Ireland. The meeting was held by videoconference in light of the ongoing COVID-19 pandemic. 2. The Summit brought
...
Multiple pandemics, numerous outbreaks, thousands of lives lost and billions of dollars of national income wiped out—all since the turn of this century, in barely 17 years—and yet the world’s investments in pandemic preparedness and response remain woefully inadequate. We know by now that the
...
Developmental disabilities are common. Yet, children with developmental disabilities have been neglected in health systems planning and policy provisions for health and continue to experience stigmatization, institutionalization, barriers to access health care and inequalities in health and educatio
...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa
...
Pregnancy and childbirth during adolescence profoundly affects the lives of millions of girls worldwide, and is a leading cause of maternal mortality and morbidity, and infant and child mortality. Every year, an estimated 21 million girls aged 15–19 years old in low- and middle-income countries be
...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the
...
Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated with a number of conditions, disability, and causes o
...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness
...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta
...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca
...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are
...
Background
Cardiovascular diseases (CVDs) are one of the global leading causes of concern due to the rising prevalence and consequence of mortality and disability with a heavy economic burden. The objective of the current study was to analyze the trend in CVD incidence, mortality, and mortality-to-
...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epide
...
